XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Ph+ and Ph-Like Adult Frontline ALL: What Is the Optimal Strategy in the TKI Era? Should MRD Be the Primary Goal? Can We Achieve CMR With Dasatinib-Blinatumomab?
Comments 0
Login to view comments.
Click here to Login
